ShareProphets : tidm

NICL

Nichols – shares slump as 2019 anticipated to be “in line with market expectations”, but 2020…

Soft drinks company Nichols (NICL) has updated including it is “pleased with… performance… sales in both the UK and International businesses are ahead of 2018… we currently anticipate full year profit before tax to be in line with market expectations”. The shares have currently responded to around 1500p… more than 12% lower!...

By Steve Moore | Published 2019-12-23 11:39:45 |

Nichols (#NICL) – argues “pleased” with 2019 performance, but warns of potentially “material” impact in 2020 from recent Saudi Arabia and UAE excise tax

2019-12-23 07:46:59

Nichols (#NICL) – H1 EPS +3%, DPS +10%, confidence from “diversified business model and sales momentum”

2019-07-17 07:17:25

Nichols (#NICL) – continues to consider FY will be in line with expectations despite “challenging” trading conditions

2019-05-01 07:10:21

Nichols (#NICL) – expects FY profit “at least in line with current market expectations”

2019-01-09 00:10:47

Nichols (#NICL) – profit performance being held back by situation in Middle East region

2017-12-19 00:19:21

Nichols (#NICL) – trading “in line”, UK soft drinks market “challenging”

2017-04-25 23:11:25

Nichols - Britain's answer to Coke keeps powering ahead, but when should investors buy it?

ShareProphets readers already know that they have the chance to buy into Coke’s long-term success through buying shares in Coca-Cola Hellenic (CCH). But there is always the choice to buy into Britain’s own answer to Coke, the humble but long-term success story that is Nichols (NICL).

By Graham Neary | Published 2016-07-21 04:14:11 |

previous 20 Page 2 of 2 (28 articles) next 0

Latest News

Show All

UPDATED: Lucian Miers & Jim Mellon are coming back to Sharestock in 2027: early bird tickets now on sale, event 15% sold out!

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

Evil Banksta weighs in on TekCapital after today’s spooftastic RNS

Good news travels fast but bad news….the case of Skinbiotherapeutics

Mothercare: the end is nigh, don’t blame Trump, I told y’all eons ago

EXPOSE: Nuburu shares in a slump post relisting on American Stock Exchange and latest accounts contain a material error

Letter to Pointon Young, former auditors to Amazing AI

Reinvesting my Satsuma Winnings

Tribal Group – “Proposed Acquisition by Main Capital Partners” provides us with another share tip winner

Quantum Data Energy - why are its shares still suspended?

Recent Comments

TOYIN18 Sep 2026

Thanks Tom, just picked some more up sub 8p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

JOHN BROWN18 Sep 2026

It's outrageous that the likes of Amy Hunt claim that women with Sydney Sweeney's body shape cannot play sport. Who said that sportswomen can't look like Ms Sweeney?

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

MICKTHELINGE18 Sep 2026

If it gets to 3p then construction will be going well and it will be well on the way to 6p+ so interested in why you would sell out then?

Reinvesting my Satsuma Winnings

TOM18 Sep 2026

Whatever Opti's intentions it will have to sell.You could say you should sell now as maybe your last chance to sell at above 8oops too late, now 7.5p to sell

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

I thought that a seasoned reader of financial statements would have clocked that OPTI's HY results to 30/6/26 classed their SBTX shares as non-current assets – meaning that management has no intention to sell them within 12 months.Maybe you assumed that they were forced to class them as non-current because SBTX shares were suspended…but no, the SBTX suspension was lifted weeks before OPTI's sign-off date.And if you believe that OPTI haven't sold all or most of their remaining SBTX shares since June 30th, I'm afraid they saw you coming.There is of course a risk that OPTI has double accounted for its SBTX shares, having included them in both non-current assets and in "cash and equivalents", which might be a fruitful line of enquiry for you.As for Skin's RNS arriving a day outside the standard 10th-20th definition of mid-month, they have had a lot of balls to juggle so a 24hr delay ought to be a cause for congratulations.Why not grab some SBTX shares this afternoon? Could be your last chance to buy back below 12p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

Notwithstanding your ad nauseam negativity on SBTX, I choose to believe the positive indications from the 8 June RNS, including "Growth continued across the company", under Current Trading and Outlook (from a chairman who never speaks with forked tongue). Accordingly, I have helped myself to a nice top-up in anticipation of a welcome trading update on Monday.

Tom Winnifrith Bearcast: Hang on for the PS in the podcast

BOBINS18 Sep 2026

lets hope the Houthis keep away from the Saudi Mines?

Reinvesting my Satsuma Winnings

Charles18 Sep 2026

Easy work for the FCA with you having laid it out.

EXPOSE: Paul Mathieson and the strike off: you might think that, I could not comment

TOM18 Sep 2026

darren has done something , really working now

Tom Winnifrith Bearcast: Hang on for the PS in the podcast

ZEDBEEKAY17 Sep 2026

I can't play it either - I'm on a laptop, and it either refuses to play or gets a few minutes in and stops